Cargando…

Editorial: Tuberculosis Drug Discovery & Development: Drug Targets, Chemical Matter, and Approaches

Detalles Bibliográficos
Autor principal:	Singh, Vinayak
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458945/ https://www.ncbi.nlm.nih.gov/pubmed/34568101 http://dx.doi.org/10.3389/fcimb.2021.755459

Ejemplares similares

Tuberculosis Drug Discovery: A Decade of Hit Assessment for Defined Targets
por: Oh, Sangmi, et al.
Publicado: (2021)

Editorial: From Apicomplexan Genes to Drug Discovery
por: Wunderlich, Gerhard, et al.
Publicado: (2021)

Editorial: Drug-resistant Mycobacterium tuberculosis
por: Boshoff, Helena I. M., et al.
Publicado: (2023)

How Mycobacterium tuberculosis drug resistance has shaped anti-tubercular drug discovery
por: Bhagwat, Amala, et al.
Publicado: (2022)

Editorial: Alternative approaches to antifungal drugs against drug-resistant fungi
por: Kovács, Renátó, et al.
Publicado: (2023)

Tools to develop antibiotic combinations that target drug tolerance in Mycobacterium tuberculosis
por: Greenstein, Talia, et al.
Publicado: (2023)

Re-Envisioning Anti-Apicomplexan Parasite Drug Discovery Approaches
por: Rangel, Gabriel W., et al.
Publicado: (2021)

Editorial: Chagas disease novel drug targets and treatments
por: Duschak, Vilma G., et al.
Publicado: (2023)

Anti-parasitic drug discovery against Babesia microti by natural compounds: an extensive computational drug design approach
por: Akash, Shopnil, et al.
Publicado: (2023)

Anti-viral drug discovery against monkeypox and smallpox infection by natural curcumin derivatives: A Computational drug design approach
por: Akash, Shopnil, et al.
Publicado: (2023)

Editorial: Development of novel reagents to reverse drug resistance in bacterial pathogens
por: Li, Yasheng, et al.
Publicado: (2022)

Central carbon metabolism remodeling as a mechanism to develop drug tolerance and drug resistance in Mycobacterium tuberculosis
por: Eoh, Hyungjin, et al.
Publicado: (2022)

Corrigendum: Anti-viral drug discovery against monkeypox and smallpox infection by natural curcumin derivatives: a computational drug design approach
por: Akash, Shopnil, et al.
Publicado: (2023)

The Deconstructed Granuloma: A Complex High-Throughput Drug Screening Platform for the Discovery of Host-Directed Therapeutics Against Tuberculosis
por: Huang, Lu, et al.
Publicado: (2018)

Drug Resistance Characteristics of Mycobacterium tuberculosis Isolates From Patients With Tuberculosis to 12 Antituberculous Drugs in China
por: Wu, Xiaocui, et al.
Publicado: (2019)

HCV Replicon Systems: Workhorses of Drug Discovery and Resistance
por: Khan, Shaheen, et al.
Publicado: (2020)

Novel Highlight in Malarial Drug Discovery: Aspartate Transcarbamoylase
por: Wang, Chao, et al.
Publicado: (2022)

Uncovering interactions between mycobacterial respiratory complexes to target drug-resistant Mycobacterium tuberculosis
por: McNeil, Matthew B., et al.
Publicado: (2022)

Mycobacterium tuberculosis KasA as a drug target: Structure-based inhibitor design
por: Rudraraju, Reshma S., et al.
Publicado: (2022)

Meta-analysis of active tuberculosis gene expression ascertains host directed drug targets
por: Ponnusamy, Nirmaladevi, et al.
Publicado: (2022)

Zinc and Iron Homeostasis: Target-Based Drug Screening as New Route for Antifungal Drug Development
por: Simm, Claudia, et al.
Publicado: (2019)

Transcriptional regulation and drug resistance in Mycobacterium tuberculosis
por: Miotto, Paolo, et al.
Publicado: (2022)

The evolving biology of Mycobacterium tuberculosis drug resistance
por: Jones, Richard M., et al.
Publicado: (2022)

Editorial: Women in antimicrobial resistance and new antimicrobial drugs
por: Wozniak, Rachel A. F., et al.
Publicado: (2023)

Advances of new drugs bedaquiline and delamanid in the treatment of multi-drug resistant tuberculosis in children
por: Zhu, Hanzhao, et al.
Publicado: (2023)

Understanding the contribution of metabolism to Mycobacterium tuberculosis drug tolerance
por: Samuels, Amanda N., et al.
Publicado: (2022)

Unraveling the mechanisms of intrinsic drug resistance in Mycobacterium tuberculosis
por: Poulton, Nicholas C., et al.
Publicado: (2022)

Evolution of Mycobacterium tuberculosis drug resistance in the genomic era
por: Nimmo, Camus, et al.
Publicado: (2022)

Trends and challenges of multi-drug resistance in childhood tuberculosis
por: Zhuang, Zengfang, et al.
Publicado: (2023)

Editorial: Drug Re-purposing for the Treatment of Bacterial and Viral Infections
por: García-Contreras, Rodolfo, et al.
Publicado: (2019)

Editorial: Hot trends in computer-aided drug design techniques
por: Scotti, Luciana, et al.
Publicado: (2023)

Withania somnifera (L.) Dunal (Ashwagandha) for the possible therapeutics and clinical management of SARS-CoV-2 infection: Plant-based drug discovery and targeted therapy
por: Singh, Manali, et al.
Publicado: (2022)

Editorial: Host-Directed Therapies for Tuberculosis
por: Costa, Diego L., et al.
Publicado: (2021)

Editorial: New insights in Mycobacterium tuberculosis
por: Natarajaseenivasan, Kalimuthusamy
Publicado: (2022)

Drug resistant tuberculosis: Implications for transmission, diagnosis, and disease management
por: Liebenberg, Dale, et al.
Publicado: (2022)

Effects of second-line anti-tuberculosis drugs on the intestinal microbiota of patients with rifampicin-resistant tuberculosis
por: Wu, Chunli, et al.
Publicado: (2023)

Editorial: Factors for the progression from latent tuberculosis infection to tuberculosis disease
por: Chen, Cheng, et al.
Publicado: (2023)

Drug Discovery and Repurposing Inhibits a Major Gut Pathogen-Derived Oncogenic Toxin
por: Metz, Paul, et al.
Publicado: (2019)

Computer-assisted drug repurposing for thymidylate kinase drug target in monkeypox virus
por: Ajmal, Amar, et al.
Publicado: (2023)

Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing
por: Boyd, Natalie K., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_al96mdv4go0auo7svprrb1sphm